Position in PTCT
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$292,183
New position
Shares Held
3,582
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#257
of 380 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $93,187,790 across 6 Biotechnology names. PTCT ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,075 | $53,684,094 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,479 | $32,099,214 | |
| 3 | MRNA |
Moderna, Inc.
|
86,677 | $6,069,989 | |
| 4 | INCY |
Incyte Corp
|
7,250 | $821,860 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
This page
|
3,582 | $292,183 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
13,029 | $220,450 |
All Filings in PTCT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292,183 | 3,582 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||